Health Canada requests that companies stop distributing ranitidine drugs in Canada while it assesses NDMA; additional products being recalled.
Additional ranitidine drugs are being recalled by four companies: Apotex Inc., Pro Doc Limitée, Sanis Health Inc., and Sivem Pharmaceuticals ULC. The lots are being recalled as they may have been manufactured using an active pharmaceutical ingredient containing an impurity, N-nitrosodimethylamine (NDMA), above acceptable levels. Please refer to the Affected Products table below for detailed information on the recalled lots.
Should any additional recalls be necessary, Health Canada will update the table below and inform Canadians.
Also, view BBC News: Zantac: CVS latest to suspend heartburn drug over cancer fears